Air strikes have shaken the Middle East after the US and Israel launched an attack against Iran, killing the country's supreme leader Ayatollah Ali Khamenei. The Guardian looks back at the seven days that ignited a war, which has already claimed the lives of more than 1,500 Seven days on, seven questions about the US-Israeli war on Iran Middle East crisis – live updates Continue reading...
Air strikes have shaken the Middle East after the US and Israel launched an attack against Iran, killing the country's supreme leader Ayatollah Ali Khamenei. The Guardian looks back at the seven days that ignited a war, which has already claimed the lives of more than 1,500 Seven days on, seven questions about the US-Israeli war on Iran Middle East crisis – live updates Continue reading...
JHVEPhoto The U.S. Food and Drug Administration has declined to approve an additional indication for Zynyz, a cancer therapy developed by Incyte ( INCY ) and MacroGenics ( MGNX ), due to issues found at a third-party manufacturing site run by Novo Nordisk’s ( NVO ) Catalent unit. In a regulatory filing on Friday, Incyte ( INCY ) said that the FDA issued a Complete Response Letter regarding its sup...
JHVEPhoto The U.S. Food and Drug Administration has declined to approve an additional indication for Zynyz, a cancer therapy developed by Incyte ( INCY ) and MacroGenics ( MGNX ), due to issues found at a third-party manufacturing site run by Novo Nordisk’s ( NVO ) Catalent unit. In a regulatory filing on Friday, Incyte ( INCY ) said that the FDA issued a Complete Response Letter regarding its supplemental Biologics License Application for Zynyz, which it currently markets for conditions including squamous cell carcinoma of the anal canal (SCAC). The sBLA, supported by data from the company’s Phase 3 POD1UM-304 trial, sought the U.S. approval of the antibody therapy in combination with chemotherapy for adults with metastatic non-small cell lung cancer. “The CRL cited the regulatory compliance of Catalent Indiana as the sole approvability issue, and did not cite other approvability concerns,” Incyte ( INCY ) said, adding it will collaborate with the FDA and Catalent to address the agency's findings and seek a resubmission of the sBLA. Separately, the company announced the EU approval for Zynyz in combination with platinum-based chemotherapy as a first-line option for adults with SCAC. More on Incyte, Novo Nordisk, etc. CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk Incyte Corporation (INCY) Presents at TD Cowen 46th Annual Health Care Conference Transcript MacroGenics drops after FDA partial clinical hold on lead program Novo’s China obesity drug posts positive mid-stage trial results
Key Points Berkshire Hathaway remains the king of cash, with plenty of ammo for acquisitions and investments. The "Magnificent Seven" companies are also sitting on tons of cash, which they'll need for the AI race. Cash is both a defensive and offensive weapon. 10 stocks we like better than Alphabet › In times of economic uncertainty and market volatility -- like the present moment -- it's wise to ...
Key Points Berkshire Hathaway remains the king of cash, with plenty of ammo for acquisitions and investments. The "Magnificent Seven" companies are also sitting on tons of cash, which they'll need for the AI race. Cash is both a defensive and offensive weapon. 10 stocks we like better than Alphabet › In times of economic uncertainty and market volatility -- like the present moment -- it's wise to look for stocks of companies with substantial cash reserves. That's because those companies will have the flexibility to deal with economic downturns, pay their bills and dividends, and even buy out struggling competitors. Indeed, the total amount of cash a business has access to can be a measure of its financial health. So it's good to know which companies have the most cash on hand. Right now, the 50 largest cash piles total more than $3.1 trillion, according to TradingView. And financials, consumer discretionary, and tech stocks hold 75% of that $3.1 trillion. Note that cash on hand generally includes physical currency, bank deposits, and highly liquid short-term securities with maturities of three months or less, like Treasury bills and money market funds. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » It may not surprise you which U.S. company has the most cash on hand. It's Berkshire Hathaway (NYSE: BRKA)(NYSE: BRKB), of course, the giant holding company that Warren Buffett built over decades. It owns some 60 companies outright and has stakes in scores of others. Berkshire currently holds about $373 billion in cash and cash equivalents. Berkshire built its enormous cash pile by retaining earnings from its operating businesses and dividends from investments, as well as by selling down some of its portfolio over many quarters. If there's a pullback in the market due to geopolitical uncertainties, Ber...
Key Points Apple is increasingly offering budget-friendly prices for its devices. The company is looking to grow its installed base and boost subscription revenue. This strategy could lead to higher margins and profits in the long run. 10 stocks we like better than Apple › Apple (NASDAQ: AAPL) has produced outstanding returns over the past 20 years. And through much of this period, the company rel...
Key Points Apple is increasingly offering budget-friendly prices for its devices. The company is looking to grow its installed base and boost subscription revenue. This strategy could lead to higher margins and profits in the long run. 10 stocks we like better than Apple › Apple (NASDAQ: AAPL) has produced outstanding returns over the past 20 years. And through much of this period, the company relied on its popular devices, most notably the iPhone, to drive sales growth. However, the tech leader's strategy moving forward will likely be a bit different: Apple will rely increasingly more on its services segment. This isn't new information. Apple's push into services has been ongoing for years. And the company's most recent product announcements gave us more insight into part of the company's strategy. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Apple's price-sensitive push Apple has historically used its strong brand name and pricing power to charge premium prices for its products, even for base models. Chip upgrades or devices that came with more memory or other added features often -- though not always -- cost more. Apple's latest product lineup doesn't exactly follow that pattern. The tech leader's new lineup features a budget-friendly iPhone 17e, for instance, whose starting price is $599. This cheaper "e" series isn't new. Apple released the iPhone 16e last year. However, the latter had the same starting price despite half the storage capacity and a less powerful chip. Then there is the MacBook Neo, the company's cheapest laptop ever, for $599. Apple's most affordable laptop used to be $999, so this is a meaningful price reduction. Now, customers can find cheaper, non-Apple options for all of these products. However, when comparing the company's most recent lineup to previous product announ...
Trump Vows To Hit 'Loser' Iran 'Very Hard' As Pezeshkian Apologizes To Gulf Even As IRGC Attacks Expand As the US-Israeli war on Iran grinds into its second week, having completed a full week of what's largely been escalation alongside no real efforts at talks, the rhetoric on all sides is still expanding just as fast as the missile exchanges. Iran continues to get bombed very intensely, while sev...
Trump Vows To Hit 'Loser' Iran 'Very Hard' As Pezeshkian Apologizes To Gulf Even As IRGC Attacks Expand As the US-Israeli war on Iran grinds into its second week, having completed a full week of what's largely been escalation alongside no real efforts at talks, the rhetoric on all sides is still expanding just as fast as the missile exchanges. Iran continues to get bombed very intensely, while several overnight ballistic missile and drone waves hit Israel . The biggest development is that Iranian President Masoud Pezeshkian says Tehran will never capitulate, pushing back after Donald Trump demanded Iran’s "unconditional surrender". But unexpectedly Pezeshkian has apologized to Gulf countries for coming under attack . But strangely, in something which suggests how little in control Pezeshkian actually is (as more likely the IRGC is running the show , also as the Council of Experts delays choosing a Khamenei successor), Iran has continued launching drones and missiles toward Israel and targets across the Gulf - again, even as officials insist Tehran has no intention of attacking neighboring states unless attacks originate from their territory. Trump, however, is already declaring victory while promising even more escalation. Posting on Truth Social, the president warned that "today Iran will be hit very hard" while saying that new targets could soon be added. "Under serious consideration for complete destruction and certain death , because of Iran’s bad behavior, are areas and groups of people that were not considered for targeting up until this moment in time," Trump wrote. He also claimed Tehran had effectively backed down in the region, saying Pezeshkian had "surrendered" to neighboring countries and "promised that it will not shoot at them anymore." According to Trump, "This promise was only made because of the relentless U.S. and Israeli attack." The president went further, declaring: Iran is no longer the 'Bully of the Middle East,' they are, instead, ‘THE LOSER...
TLDR NVDA dropped ~3% on Friday, closing around $177.83, down from a prior close of $183.34 Reports of new U.S. rules requiring government approval for nearly all overseas AI chip sales rattled investors Nvidia reportedly halted H200 shipments to China to redirect TSMC capacity toward new Rubin platforms Despite the drop, Q4 revenue came in at $68.13 billion — up 73.2% year-over-year — beating est...
TLDR NVDA dropped ~3% on Friday, closing around $177.83, down from a prior close of $183.34 Reports of new U.S. rules requiring government approval for nearly all overseas AI chip sales rattled investors Nvidia reportedly halted H200 shipments to China to redirect TSMC capacity toward new Rubin platforms Despite the drop, Q4 revenue came in at $68.13 billion — up 73.2% year-over-year — beating estimates Analyst consensus price target sits at $273.64, with 47 Buy ratings and only 2 Hold ratings 💥 Find the Next KnockoutStock! Get live prices, charts, and KO Scores from KnockoutStocks.com , the data-driven platform ranking every stock by quality and breakout potential. NVIDIA (NVDA) fell around 3% on Friday, with the stock touching an intraday low of $176.82 before settling near $177.83. The prior close was $183.34. Volume came in at roughly 187.4 million — about 4% above the daily average. NVIDIA Corporation, NVDA The selling pressure came largely from fresh reports about potential new U.S. export rules. Officials have reportedly drafted regulations that would require government approval for nearly all overseas sales of advanced AI chips. The rules would vary in complexity based on shipment size. Orders of 200,000 chips or more could require foreign investment in U.S. data centers or security guarantees, according to Bloomberg and Reuters. The Commerce Department said it was not returning to Biden’s “AI diffusion” framework, pointing to recent AI chip deals struck in the Middle East as the model going forward. But those Middle East deals weren’t exactly smooth. The U.S. approved the sale of up to 70,000 advanced chips to firms in the UAE and Saudi Arabia — only after months of delays tied to investment discussions and security concerns. That timeline raises questions about how quickly deals could get done if a similar process applies globally. China Headwinds Add to the Pressure NVDA also faced pressure from separate reports that it halted H200 chip shipments to China...
madisonwi/iStock via Getty Images Vital Farms, Inc. ( VITL ) has become a sore spot in my portfolio. My two buy ratings are both largely in the red. The stock was most recently hammered following their most recent earnings. The stock saw its price drop by nearly 20% in a single day and is now down by 35% over the past year. Seeking Alpha The company showed the first signs of cracks in its egg grow...
madisonwi/iStock via Getty Images Vital Farms, Inc. ( VITL ) has become a sore spot in my portfolio. My two buy ratings are both largely in the red. The stock was most recently hammered following their most recent earnings. The stock saw its price drop by nearly 20% in a single day and is now down by 35% over the past year. Seeking Alpha The company showed the first signs of cracks in its egg growth story in the latest earnings report. The company beat revenue estimates but missed on the earnings. The company had beat earnings estimates in 15 straight quarters until the latest Q4 result. It also lowered guidance for the year. Despite the negative news, the company did still show strong growth. It also maintained its long-term revenue and profit targets. I understand why the company saw some selling pressure based upon the quarterly results. I think the selloff was overdone and has pushed the company to a point where it is undervalued. Financials The company continued to show growth when it reported its results . But it did fall short of earning estimates and lowered revenue guidance going forward. The company reported revenues of $213.6 million for the quarter, good for growth of 28.7% for the year. The revenue actually beat estimates, but the earnings fell short. The company reported EPS of $0.35 versus the $0.39 expected. This was growth of more than 50% from the prior year. Adjusted EBITDA also increased significantly year over year, going from $19.1 million to $29.2 million. So the growth story is still intact, with revenues growing by nearly 30% and earnings by over 50%. The concern in the quarter is that the company has a history of beating earnings, not falling short. The other negative aspect of the report that helped cause the stock drop was the weakened guidance. The company provided a revenue estimate of $900 million to $920 million, which is below the estimate of $938.6 million. The company lost approximately $200 million in market cap. I don’t think a d...
Gustavo Muñoz Soriano/iStock via Getty Images This week I issued an article titled Stop Panicking And Start Buying BDCs . I introduced a broader perspective on BDC credit risk and provided a solid ground for investors for going against the heard - i.e., to scoop up high-quality names before the negative emotions settle. As it is usually the case, in the comment section there was an interesting cha...
Gustavo Muñoz Soriano/iStock via Getty Images This week I issued an article titled Stop Panicking And Start Buying BDCs . I introduced a broader perspective on BDC credit risk and provided a solid ground for investors for going against the heard - i.e., to scoop up high-quality names before the negative emotions settle. As it is usually the case, in the comment section there was an interesting chatter, where one comment specifically stuck in my mid. It was something along the lines of me suggesting investors to load up the truck with BDCs even though in early January this year I was warning investors that system-wide BDC dividend cuts are imminent. Obviously, approaching BDC dividend cuts and high-quality BDC buying are not mutually exclusive. Even if a BDC is about to cut its dividend, it does not mean that it is a bad investment. There is a difference between whether the cut is driven by falling SOFR, which BDC managers cannot control and cuts that stem from a bad underwriting, which BDC can and should control. However, the dividend aspect was not that caused me to write this article or do the explaining. It was more about the notion of "buying BDCs hand over fist", which is totally the opposite message what I tried to convey. So, in this article I will try to take a step back and provide the other side of the BDC bull case, which is more subtle, perhaps a bit technical, but definitely critical to understand. My hope is that these three messages below will once again cement the importance of sticking to high-quality BDCs instead of venturing into indiscriminate buying spree. The risks are real, many discounts are there for a reason and I have personally (before SaaS drama) experienced the consequences of not appreciating what I will now highlight below. #1: Weighted averages are just that - averages Most BDC investors have probably observed that such metrics as interest rate coverage, debt to EBITDA, loan to value etc. are used by the managers to capture the healt...
Units of Energy Transfer (ET +0.38%) have rallied more than 13% this year. That surge has pushed the midstream giant's price near $19 per unit. Fueling the master limited partnership's (MLP) rally has been a combination of a growth reacceleration and higher oil prices. Here's a look at whether the MLP's stock price could reach $30 in the coming years. The reacceleration has begun Last year was a b...
Units of Energy Transfer (ET +0.38%) have rallied more than 13% this year. That surge has pushed the midstream giant's price near $19 per unit. Fueling the master limited partnership's (MLP) rally has been a combination of a growth reacceleration and higher oil prices. Here's a look at whether the MLP's stock price could reach $30 in the coming years. The reacceleration has begun Last year was a bit of an outlier for Energy Transfer. The MLP grew its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) by 3.2%. That's much slower than the 10% compound annual growth rate it delivered from 2020 through 2024. The pipeline company had fewer growth catalysts last year, as it didn't complete any acquisitions, only finished a few expansion projects, and oil prices slumped. However, this year will be different. Energy Transfer expects its adjusted earnings to rise by more than 10% at the midpoint of its guidance range. The company will benefit from the ramp-up and completion of several major expansion projects this year. Meanwhile, both of its affiliated MLPs have recently completed acquisitions, which will boost its bottom line. Additionally, oil prices are rising, which should also bolster its financial results. Expand NYSE : ET Energy Transfer Today's Change ( 0.38 %) $ 0.07 Current Price $ 18.74 Key Data Points Market Cap $64B Day's Range $ 18.59 - $ 18.83 52wk Range $ 14.60 - $ 19.30 Volume 16M Avg Vol 15M Gross Margin 12.27 % Dividend Yield 7.07 % The fuel to continue growing Energy Transfer could continue to grow at an accelerated rate over the next several years. It has a large backlog of expansion projects, including the $2.7 billion Hugh Brinson Pipeline and the $5.6 billion Transwestern Pipeline expansion project. It currently has secured projects that should enter commercial service through 2030. Meanwhile, it has more opportunities in the pipeline, notably to expand its gas infrastructure to support growing demand by data centers an...
"If the aggression… continues there is no doubt we will defend ourselves," he said. "And if they want to use these military bases - although we don't want to do that -there is no doubt we will defend ourselves accordingly."
"If the aggression… continues there is no doubt we will defend ourselves," he said. "And if they want to use these military bases - although we don't want to do that -there is no doubt we will defend ourselves accordingly."
In early March 2026, Akamai Technologies detailed a four-year, US$200,000,000 service agreement to provide a multi-thousand NVIDIA Blackwell GPU cluster and related cloud infrastructure to a major U.S. AI-focused tech company, while also urging shareholders in a preliminary proxy to vote against a proposal for expanded political spending disclosures. The AI compute deal, which relies on Akamai’s r...
In early March 2026, Akamai Technologies detailed a four-year, US$200,000,000 service agreement to provide a multi-thousand NVIDIA Blackwell GPU cluster and related cloud infrastructure to a major U.S. AI-focused tech company, while also urging shareholders in a preliminary proxy to vote against a proposal for expanded political spending disclosures. The AI compute deal, which relies on Akamai’s recently expanded distributed cloud footprint and large Blackwell GPU acquisition, underscores how the company is repositioning from its content delivery roots toward higher-value AI and security infrastructure services. We’ll now examine how this large AI compute agreement and GPU-backed cloud expansion could reshape Akamai’s investment narrative around growth, risk, and execution. Uncover the next big thing with 31 elite penny stocks that balance risk and reward. Akamai Technologies Investment Narrative Recap To own Akamai today, you have to believe its transition from legacy content delivery to higher-value security and AI infrastructure can offset CDN headwinds and rising capital intensity. The US$200,000,000, four-year AI compute agreement looks supportive of the near term growth catalyst in Cloud Infrastructure Services, but it also amplifies the key risk that heavy GPU and data center spending crimps margins if large contracts do not ramp as planned. The recent NVIDIA-powered Guardicore segmentation announcement for operational technology and industrial control systems ties directly into Akamai’s security growth catalyst, which sits alongside AI compute as a core pillar of the thesis. If enterprises continue to adopt micro segmentation and Zero Trust tools to protect critical infrastructure, this could help counterbalance margin pressure from AI-related CapEx and deepen Akamai’s mix of higher-value security revenue streams. Yet beneath the appeal of AI and security growth, investors should be aware that rising CapEx and customer concentration could still... Read the f...
Galeanu Mihai/iStock via Getty Images NNN REIT ( NNN ) is one of the cornerstones of my dividend portfolio - I'm a long-oriented investor with a strong tilt towards income-generating assets. That's why REITs have always been one of my favorite ways to invest. I don't think I have to tell you - not all REITs have been created equal (or should I say managed equally?). Throughout the years, I've revi...
Galeanu Mihai/iStock via Getty Images NNN REIT ( NNN ) is one of the cornerstones of my dividend portfolio - I'm a long-oriented investor with a strong tilt towards income-generating assets. That's why REITs have always been one of my favorite ways to invest. I don't think I have to tell you - not all REITs have been created equal (or should I say managed equally?). Throughout the years, I've reviewed numerous REITs, and several have caught my attention for standing out from the rest. Regardless of the criteria you prefer to look at - income potential and stability, business metrics, valuation, track record, or business model - truly top picks perform strongly from many perspectives. I think NNN is such a case. It has many qualities, and a few of them can be easily ranked as "the best" in the entire sector - that's why I've been bullish on NNN since the first time I covered it . But I'm not going to sugarcoat it. NNN is not as attractive now as it was months ago. Don't get me wrong, I still think it can be a worthy addition to a well-structured portfolio, but those who bought when I recommended it last time managed to secure a better price. Since the last time I covered NNN , its stock price has increased by over 13%, delivering a total return of 15%. Seeking Alpha Now, I see that NNN has published its quarterly data for Q4 2025. On top of that, I saw a dynamic upward movement in its stock price, and these are the reasons why I decided to prepare a follow-up coverage. I will present you with three key reasons why I still consider NNN buyable. Three Reasons Why NNN Is Still A Buy Great diversification in a highly attractive business model I always like to look at the diversification from a few perspectives, namely: tenant structure, industry exposure, and geography. I think NNN has one of the best portfolio structures from the perspective of diversification. Firstly, I see that no tenant represents a share in ABR higher than 5%, with the largest one responsible for 4...
Former Secretary of State Antony Blinken discussed with Bloomberg's David Gura the Trump administration’s evolving justifications for the U.S. war against Iran, warning about unclear imminent threats and serious risks of unintended regional escalation on "Bloomberg This Weekend." (Source: Bloomberg)
Former Secretary of State Antony Blinken discussed with Bloomberg's David Gura the Trump administration’s evolving justifications for the U.S. war against Iran, warning about unclear imminent threats and serious risks of unintended regional escalation on "Bloomberg This Weekend." (Source: Bloomberg)
mbbirdy/E+ via Getty Images Wall Street finished the week lower as escalating conflict in the Middle East fueled volatility across commodity markets. Oil prices surged during the week, lifting shares of oil and gas producers, refiners, and energy infrastructure companies. West Texas Intermediate crude oil ( CL1:COM ) climbed to a high of about $92.61 per barrel, while Brent crude ( CO1:COM ) rose ...
mbbirdy/E+ via Getty Images Wall Street finished the week lower as escalating conflict in the Middle East fueled volatility across commodity markets. Oil prices surged during the week, lifting shares of oil and gas producers, refiners, and energy infrastructure companies. West Texas Intermediate crude oil ( CL1:COM ) climbed to a high of about $92.61 per barrel, while Brent crude ( CO1:COM ) rose above $94.55. Meanwhile, U.S. Treasury yields moved higher after the ISM Manufacturing Prices Index came in stronger than expected in February, adding to concerns about persistent inflation. For the week, the S&P ( SP500 ) lost -2.0%, while the tech-heavy Nasdaq Composite ( COMP:IND ) dipped -1.2%, and the blue-chip Dow ( DJI ) fell -3.0%. Here’s what caught investor attention this week: Berkshire Hathaway ( BRK.A ) ( BRK.B ) reported that its cash and short-term Treasury holdings surged to a record $373.3B. This was up 12% from the previous year. The firm also said it is repurchasing shares of its class A and class B common stock, with CEO Greg Abel buying shares worth $15.3M. Apple ( AAPL ) debuted several new products as part of a multi-day rollout of hardware announcements. This included the MacBook Neo, a new, budget-friendly laptop starting at about $599. South Korea’s main stock index, the KOSPI, plunged more than 7% on Tuesday, with technology giants Samsung Electronics ( SSNLF ) and SK Hynix (HXSC.F) among the biggest decliners. The rout was tied to broad global risk aversion, as the conflict in Iran ratcheted up concerns about energy prices and the long-term geopolitical environment. Billionaire Leo KoGuan, best known for the large Tesla stake, posted this week that he bought 1M shares of Nvidia ( NVDA ) , reaffirming his bullish stance on artificial intelligence and the semiconductor maker’s central role in the AI ecosystem. Optical networking firms Lumentum ( LITE ) and Coherent ( COHR ) were in focus on Monday after Nvidia ( NVDA ) disclosed expanded partnershi...
Key Points President Donald Trump recently nominated Kevin Warsh to be the new Fed chair in May. Most outgoing Fed chairs will also step down from the Fed's Board of Governors, even if they have time left in their 14-year term. However, outgoing Fed chairs don't have to step down from the board. Some wonder if Powell will stay on. These 10 stocks could mint the next wave of millionaires › After mo...
Key Points President Donald Trump recently nominated Kevin Warsh to be the new Fed chair in May. Most outgoing Fed chairs will also step down from the Fed's Board of Governors, even if they have time left in their 14-year term. However, outgoing Fed chairs don't have to step down from the board. Some wonder if Powell will stay on. These 10 stocks could mint the next wave of millionaires › After months of criticizing current Federal Reserve Chair Jerome Powell, President Donald Trump has finally chosen a successor for Powell's term, which ends in May. Assuming Congress confirms him, Kevin Warsh will become the new Fed chair. Warsh served on the Federal Reserve Board of Governors between 2006 and 2011, and has also spent many years working with the legendary investor Stanley Druckenmiller. While Trump may think that his troubles with Powell are behind him, there is still one way that Powell could prove to be a thorn in Trump's side for the rest of his term. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The way Powell can retain his influence at the Fed It's customary for the departing Fed chair to step down from the Fed's Board of Governors once their term as chair ends. However, Powell's term on the Fed board runs through 2028, so he could choose to stay on if he wanted to. This has occurred before. In the late 1940s, Marriner Eccles, the seventh chair of the Fed, remained on the Fed board because he believed his removal by President Harry Truman was politically motivated at the time. Powell, who has expressed concern about Trump's meddling at the Fed, could decide to stay if he believes the Fed's independence is at risk. In fact, it's possible the U.S. Department of Justice subpoenaed Powell regarding a criminal investigation into a multibillion-dollar renovation of the Federal Reserve's new hea...